232 related articles for article (PubMed ID: 33315682)
1. 68Ga-Fibroblast Activation Protein Inhibitor, a Promising Radiopharmaceutical in PET/CT to Detect the Primary and Metastatic Lesions of Chromophobe Renal Cell Carcinoma.
Pang Y; Wei J; Shang Q; Zhao L; Chen H
Clin Nucl Med; 2021 Feb; 46(2):177-179. PubMed ID: 33315682
[TBL] [Abstract][Full Text] [Related]
2. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
Xie F; Fu L; Zhou W
Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Chen EJ; Tan TH; Chew MT; Chye PC
Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-PSMA PET/CT Detecting Metastatic Lesion of RCC: Missed on 18F-FDG PET/CT.
Jha S; Hemrom A; Shamim SA; Barwad A; Batra A
Clin Nucl Med; 2023 Jun; 48(6):e294-e296. PubMed ID: 37133514
[TBL] [Abstract][Full Text] [Related]
6. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Has Simsek D; Civan C; Erdem S; Sanli Y
Clin Nucl Med; 2021 Jul; 46(7):579-581. PubMed ID: 33782292
[TBL] [Abstract][Full Text] [Related]
7. Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Sasikumar A; Joy A; Nanabala R; Unni M; Tk P
Clin Nucl Med; 2016 Dec; 41(12):e517-e519. PubMed ID: 27749421
[TBL] [Abstract][Full Text] [Related]
8. 18F-PSMA-1007 PET/CT for Initial Staging of Renal Cell Carcinoma in an End-Stage Renal Disease Patient.
Marafi F; Sasikumar A; Aldaas M; Esmail A
Clin Nucl Med; 2021 Jan; 46(1):e65-e67. PubMed ID: 33181733
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-FAPI-04 PET/CT in Solitary Choroid Plexus Metastasis From Renal Cell Carcinoma.
Yang J; Dong A; Zuo C
Clin Nucl Med; 2022 Oct; 47(10):885-887. PubMed ID: 36067086
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Liu Y; Wang G; Yu H; Wu Y; Lin M; Gao J; Xu B
Nucl Med Commun; 2020 Dec; 41(12):1299-1305. PubMed ID: 32941403
[TBL] [Abstract][Full Text] [Related]
11. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
12. The Isolated Humeral Metastasis as the Initial Presentation of Renal Cell Carcinoma Revealed by 18 F-FDG PET/CT.
Hou G; Zhang W; Zheng R
Clin Nucl Med; 2023 Jun; 48(6):538-539. PubMed ID: 36976679
[TBL] [Abstract][Full Text] [Related]
13. Lesion detection by [
Verhoeff SR; van Es SC; Boon E; van Helden E; Angus L; Elias SG; Oosting SF; Aarntzen EH; Brouwers AH; Kwee TC; Heskamp S; Hoekstra OS; Verheul H; van der Veldt AAM; de Vries EGE; Boerman OC; van der Graaf WTA; Oyen WJG; van Herpen CML
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1931-1939. PubMed ID: 31172212
[TBL] [Abstract][Full Text] [Related]
14. Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake.
Xia X; Hu F; Qin C; Liu F; Lan X
Clin Nucl Med; 2019 Jan; 44(1):38-39. PubMed ID: 30371589
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG and 68GA-Prostate-Specific Membrane Antigen PET/CT Perform Better Than CT Alone in Restaging Papillary Renal Cell Carcinoma Recurrence.
Gasparro D; Scarlattei M; Manuguerra R; Guglielmo P; Migliari S; Sammartano A; Baldari G; Maestroni U; Silini EM; Ruffini L
Clin Nucl Med; 2021 Sep; 46(9):e458-e460. PubMed ID: 34374683
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in Malignant Peritoneal Mesothelioma.
Gündoğan C; Güzel Y; Kömek H; Etem H; Kaplan İ
Clin Nucl Med; 2022 Feb; 47(2):e113-e115. PubMed ID: 34392282
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
[TBL] [Abstract][Full Text] [Related]
18. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
[TBL] [Abstract][Full Text] [Related]
19. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
Ge J; Zuo C; Guan Y; Liang Z
Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
[TBL] [Abstract][Full Text] [Related]
20. Perirenal Infiltration of Signet Ring Cell Colon Carcinoma Shown by 68Ga-FAPI PET/CT.
Güzel Y; Kaplan İ; Kepenek F; Söğütçü N; Kömek H
Clin Nucl Med; 2022 Jul; 47(7):e509-e512. PubMed ID: 35675142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
